Meeting Abstract

Development and validation of a new patient reported outcome measure for systemic sclerosis: the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire


Authors listBecker, M. O.; Dobrota, R.; Garaiman, A.; Fligelstone, K.; Kennedy, A.; Roennow, A.; Allanore, Y.; Carreira, P.; Czirjak, L.; Denton, C.; Hesselstrand, R.; Sandqvist, G.; Kowal-Bielecka, O.; Bruni, C.; Matucci-Cerinic, M.; Mihai, C.; Gheorghiu, A. M.; Mueller-Ladner, U.; Sexton, J.; Heiberg, T.; Distler, O.

Publication year2020

Pages12S-13S

JournalSwiss Medical Weekly

ISSN1424-7860

eISSN1424-3997

PublisherSMW supporting association



Citation Styles

Harvard Citation styleBecker, M., Dobrota, R., Garaiman, A., Fligelstone, K., Kennedy, A., Roennow, A., et al. (2020) Development and validation of a new patient reported outcome measure for systemic sclerosis: the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire, Swiss Medical Weekly, pp. 12S-13S

APA Citation styleBecker, M., Dobrota, R., Garaiman, A., Fligelstone, K., Kennedy, A., Roennow, A., Allanore, Y., Carreira, P., Czirjak, L., Denton, C., Hesselstrand, R., Sandqvist, G., Kowal-Bielecka, O., Bruni, C., Matucci-Cerinic, M., Mihai, C., Gheorghiu, A., Mueller-Ladner, U., Sexton, J., ...Distler, O. (2020). Development and validation of a new patient reported outcome measure for systemic sclerosis: the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire. Swiss Medical Weekly, 12S-13S.


Last updated on 2025-02-04 at 00:41